Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Friendly Bacteria Offers Hope For Ulcerative Colitis Patients

17.08.2004


A type of ‘friendly bacteria’ has been the key for researchers at the University of Dundee who have just developed a treatment that offers the opportunity of new therapies for the management of one of the UK’s most common forms of inflammatory bowel disease - ulcerative colitis. Results from a four-week patient trial led by Professor George Macfarlane showed that many of the patients’ symptoms were dramatically reduced to near normal levels.



Affecting an estimated fifty thousand people in the UK, with a particularly high incidence rate in north east Scotland, ulcerative colitis is an acute and chronic disease that causes inflammation and sores, called ulcers, in the lining of the large bowel.

After studying the bowel wall of colitis patients and healthy volunteers, the team made an important discovery. The levels of a specific type of friendly bacteria were 30 times less in colitis patients than in healthy people. As well as stimulating the immune system and offering anti-cancer properties, many of these organisms have anti-inflammatory effects, and after noting that the particular types of this bacteria were also different in colitis patients, the researchers set about developing substitute organisms that could help colitis patients.


As a result, Professor Macfarlane and his team developed a probiotic, which together with a carbohydrate source forms a ‘synbiotic’ and was given to the colitis patients as a substitute for the anti-inflammatory effects that the naturally occurring ‘friendly bacteria’ offer to healthy people. In a four-week trial with active ulcerative colitis patients, the researchers monitored the effect of the synbiotic.

Ulcerative colitis patients commonly experience abdominal pain and diarrhoea but fatigue, weight loss, rectal bleeding, loss of appetite and loss of body fluids and nutrients can affect some patients. The trial results were dramatic showing that the synbiotic had a highly significant effect on inflammatory molecules in the bowel wall, largely reducing the pain and discomfort commonly experienced by ulcerative colitis patients. Molecular and clinical tests showed that many symptoms associated with colitis were reduced to near normal levels, and unlike many other treatments, there are no side effects.

Professor George Macfarlane said, “This is an important development in the search for an effective treatment for ulcerative colitis. The trial results show that participants receiving the synbiotic stopped experiencing pain, diarrhoea and other symptoms commonly associated with the disease. This meant that they could go about their daily lives without worrying about the symptoms that makes living with the disease a struggle.”

The work is ongoing and the research team is also investigating the effects that both diet and age have on the gut. A multidisciplinary team of ten have worked on the project that has seen laboratory based observations translated to the clinical environment - the patients. The project was funded by the Medical Research Council.

Angela Durcan | alfa
Further information:
http://www.dundee.ac.uk

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>